Angiographic Catheters Market Outlook (2023 to 2033)

The global angiographic catheters market is likely to reach US$ 2,215.4 million by 2033, up from US$ 1,451.0 million in 2023, advancing at a CAGR of 4.3% during the forecast period.

The angiographic catheters provide therapeutic agents and radiopaque media to the selected sites in the vascular system, and the same is catching the attention of market players. In addition, the angiographic catheter is also used to lead a guide wire to the targeted site, and the demand for angiographic catheters is gaining momentum as they are also used for the treatment of cardiac diseases.

The thin wall structure of the catheter allows the flow rate up to 23 ml/sec (saline), in turn widening its application, resulting in an upsurge in sales of these catheters. The market growth is further fostered by the rising demand for these catheters owing to the availability of angiographic catheters in different shapes.

Attributes Details
Angiographic Catheters Market Share (2022) US$ 1,402.8 million
Angiographic Catheters Market Share (2023) US$ 1,451.0 million
Angiographic Catheters Market Share (2033) US$ 2,215.4 million
Angiographic Catheters Market Share (2023 to 2033) 4.3%

The angiographic catheters demand analysis is swayed by the aid provided by it in combining the diagnosis and treatment in a single procedure and making possible, detailed, and accurate pictures of the blood vessels. The elimination of the need for any surgery by angiographic catheters is also considered to significantly impact the demand for the product worldwide.

The global market for angiographic catheters is expected to witness moderate growth over the forecast period due to the increasing adoption of angiographic procedures. External factors such as the increasing use of e-commerce and logistics services in developing and under-developing economies are also fuelling the angiographic catheter market growth.

Increased potential for the expansion of the angiographic catheter market is likely to result from the rise in research and development activities. Most research and development efforts are focused on a method that pinpoints the exact location of the bleeding and can be applied to medical procedures like embolization or vasopressin injection, auguring well for future market trends.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Angiographic Catheters Market Dynamics?

A surge in the incidence of cardiac vascular diseases (CVDs) and a rise in demand for accurate diagnosis and procedural equipment in the global healthcare sector are increasing the sales of angiographic catheters. The government's growing efforts to raise public awareness also have a significant impact on the market growth rate for angiographic catheters.

The angiographic catheter market size is expanded with the development of technology which is another important aspect. However, the high cost of angiographic procedures and other components may hamper the growth of the global angiographic catheter market. In addition to this, the availability of alternative therapies and complications associated with angiographic catheters can also dwindle the global angiographic catheters market size.

What Factors are Likely to Contribute to the North America’s Leading Position in the Angiographic Catheters Market?

Due to the increased adoption of cutting-edge technology and the concentration of key market players in North America, this area held a monopoly on the angiographic catheter market, with a share of 33.1% captured in 2022.

The incidence of cardiovascular disorders is rising, and the number of elderly people is expanding, both of which are likely to accelerate the region’s market growth. The region’s angiographic catheter market trends are shaped by the rapid introduction of new products to the market, being accelerated by the strong Research and Development investment in the industry.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Growth Prospects for the Angiographic Catheters Market in Europe?

Western Europe is expected to be the second largest market for angiographic catheters due to the increasing government support for people undergoing coronary angioplasty through reimbursement and thus contributing to the region's angiographic catheters market share of 28.2% captured in 2022.

In addition, the aging population base and rising sterile and disposable catheter demand support the market expansion. The angiographic catheter market's technological developments are also likely to open up a wide array of market opportunities in the area.

How is the Start-up Ecosystem in the Angiographic Catheters Market?

Business models vary throughout time, sometimes as a consequence of changes in the market and other times as a result of the introduction of new technology, which leads to the formation of fresh, intriguing trends.

  • The AngioSculpt Scoring Balloon Catheter was created for both coronary and peripheral arterial disease by the Israeli-American firm Angioscore.

FDA-approved and CE-marked products are available. In June 2014, it was purchased by Spectranetics.

  • Cleerly Coronary, a start-up that analyses heart scans using A.I. driven imaging, announced a US$ 43 million Series B funding. The cash arrives just as a new method of heart disease screening appears to be on the horizon.

James K. Min, MD, the head of the Dalio Institute for Cardiac Imaging at New York Presbyterian Hospital/Weill Cornell Medical College, founded Cleerly in 2017. The business, which employs 60 people and has a total funding of US$ 54 million, uses A.I. to interpret intricate heart CT scans.

The start-up's goal is to provide analysis of finely detailed images of the human heart that have been looked at by artificial intelligence. This research is based on pictures obtained using a Cardiac Computer Tomography Angiogram (CTA), a relatively new but quickly expanding method of detecting plaques.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What is the Competition Landscape in the Angiographic Catheters Market?

In recent years, manufacturers have improved the surface properties of angiographic catheters. The market for angiographic catheters is very fragmented and has only a few prominent players.

Recent developments in the market are :

  • The United States Food and Drug Administration (FDA) has approved an expanded indication for Teleflex Incorporated's specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI), the leading global provider of medical technologies announced in February 2022.
  • Announcing the first minimally invasive heart treatment in July 2023, Royal Philips, a world leader in healthcare technology, used its brand-new real-time 3D intracardiac echocardiography (ICE) device. Mohamad Adnan Alkhouli, M.D., performed the Left Atrial Appendage Occlusion (LAAO) operation at the Mayo Clinic in Minnesota, the United States.
  • The Chinese health authorities have given their approval for the AngioPlus system, a piece of medical equipment that was presented by Pulse Medical Imaging Technology Co.
  • PreCARDIA, the creator of a proprietary catheter and controller, was acquired by Abiomed (NASDAQ: ABMD), expanding the range of choices available to patients with acute decompensated heart failure (ADHF).

Key Players in the Global Market

  • AngioDynamics Inc.
  • Terumo Europe NV
  • Medtronic
  • Merit Medical Systems Inc.
  • OSCOR Inc.
  • B. Braun Melsungen AG
  • Cardinal Health
  • InSitu Technologies Inc.
  • BVM Medical Limited
  • Precision Extrusion Inc.
  • Cardiva
  • C. R. Bard Inc.
  • Boston Scientific Corporation

Scope of the Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ Million for Value
Key Regions Covered North America; Latin America; Europe; Asia Pacific; Middle East & Africa (MEA)
Key Countries Covered United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others
Key Segments Covered Product Type, End-use, Region
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Angiographic Catheters Market Segmentation

By Product Type :

  • Scoring Balloon Catheters
  • Cutting Ballon Catheters

By End-use :

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Angiographic Catheters Market?

The market is likely to reach US$ 2,215.4 million by 2033.

Who are the Key Angiographic Catheters Market Players?

Key players include AngioDynamics Inc., Medtronic, Terumo Europe NV, and more.

Which is the Key Segment by Product Type?

Scoring balloon catheters and cutting balloon catheters are key segments.

What is the Go-to Market Strategy?

Increasing adoption of hybrid operating rooms bolsters the market.

Which are the Key Asian Countries in the Angiographic Catheters Market?

Key Asian countries include China, Japan, and South Korea.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
        5.3.1. Scoring Balloon Catheters
        5.3.2. Cutting Balloon Catheters
    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033
        6.3.1. Hospitals
        6.3.2. Ambulatory Surgical Centers
        6.3.3. Specialty Clinics
        6.3.4. Others
    6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Western Europe
        7.3.4. Eastern Europe
        7.3.5. South Asia and Pacific
        7.3.6. East Asia
        7.3.7. Middle East and Africa
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        8.2.1. By Country
            8.2.1.1. USA
            8.2.1.2. Canada
        8.2.2. By Product Type
        8.2.3. By End Use
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Product Type
        8.3.3. By End Use
    8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Product Type
        9.2.3. By End Use
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product Type
        9.3.3. By End Use
    9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. UK
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Western Europe
        10.2.2. By Product Type
        10.2.3. By End Use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product Type
        10.3.3. By End Use
    10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Poland
            11.2.1.2. RUSAa
            11.2.1.3. Czech Republic
            11.2.1.4. Romania
            11.2.1.5. Rest of Eastern Europe
        11.2.2. By Product Type
        11.2.3. By End Use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product Type
        11.3.3. By End Use
    11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. India
            12.2.1.2. Bangladesh
            12.2.1.3. Australia
            12.2.1.4. New Zealand
            12.2.1.5. Rest of South Asia and Pacific
        12.2.2. By Product Type
        12.2.3. By End Use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product Type
        12.3.3. By End Use
    12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. China
            13.2.1.2. Japan
            13.2.1.3. South Korea
        13.2.2. By Product Type
        13.2.3. By End Use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product Type
        13.3.3. By End Use
    13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Product Type
        14.2.3. By End Use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product Type
        14.3.3. By End Use
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2022
            15.1.2.1. By Product Type
            15.1.2.2. By End Use
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2022
            15.2.2.1. By Product Type
            15.2.2.2. By End Use
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2022
            15.3.2.1. By Product Type
            15.3.2.2. By End Use
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2022
            15.4.2.1. By Product Type
            15.4.2.2. By End Use
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2022
            15.5.2.1. By Product Type
            15.5.2.2. By End Use
    15.6. UK
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2022
            15.6.2.1. By Product Type
            15.6.2.2. By End Use
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2022
            15.7.2.1. By Product Type
            15.7.2.2. By End Use
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2022
            15.8.2.1. By Product Type
            15.8.2.2. By End Use
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2022
            15.9.2.1. By Product Type
            15.9.2.2. By End Use
    15.10. Poland
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2022
            15.10.2.1. By Product Type
            15.10.2.2. By End Use
    15.11. RUSAa
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2022
            15.11.2.1. By Product Type
            15.11.2.2. By End Use
    15.12. Czech Republic
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2022
            15.12.2.1. By Product Type
            15.12.2.2. By End Use
    15.13. Romania
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2022
            15.13.2.1. By Product Type
            15.13.2.2. By End Use
    15.14. India
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2022
            15.14.2.1. By Product Type
            15.14.2.2. By End Use
    15.15. Bangladesh
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2022
            15.15.2.1. By Product Type
            15.15.2.2. By End Use
    15.16. Australia
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2022
            15.16.2.1. By Product Type
            15.16.2.2. By End Use
    15.17. New Zealand
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2022
            15.17.2.1. By Product Type
            15.17.2.2. By End Use
    15.18. China
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2022
            15.18.2.1. By Product Type
            15.18.2.2. By End Use
    15.19. Japan
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2022
            15.19.2.1. By Product Type
            15.19.2.2. By End Use
    15.20. South Korea
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2022
            15.20.2.1. By Product Type
            15.20.2.2. By End Use
    15.21. GCC Countries
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2022
            15.21.2.1. By Product Type
            15.21.2.2. By End Use
    15.22. South Africa
        15.22.1. Pricing Analysis
        15.22.2. Market Share Analysis, 2022
            15.22.2.1. By Product Type
            15.22.2.2. By End Use
    15.23. Israel
        15.23.1. Pricing Analysis
        15.23.2. Market Share Analysis, 2022
            15.23.2.1. By Product Type
            15.23.2.2. By End Use
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Product Type
        16.3.3. By End Use
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. AngioDynamics, Inc.
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
                17.1.1.5.2. Product Strategy
                17.1.1.5.3. Channel Strategy
        17.1.2. Terumo Europe NV
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
                17.1.2.5.2. Product Strategy
                17.1.2.5.3. Channel Strategy
        17.1.3. Medtronic
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
                17.1.3.5.2. Product Strategy
                17.1.3.5.3. Channel Strategy
        17.1.4. Merit Medical Systems, Inc.
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
                17.1.4.5.2. Product Strategy
                17.1.4.5.3. Channel Strategy
        17.1.5. OSCOR Inc.
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
                17.1.5.5.2. Product Strategy
                17.1.5.5.3. Channel Strategy
        17.1.6. B. Braun Melsungen AG
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
                17.1.6.5.2. Product Strategy
                17.1.6.5.3. Channel Strategy
        17.1.7. Cardinal Health
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
                17.1.7.5.2. Product Strategy
                17.1.7.5.3. Channel Strategy
        17.1.8. InSitu Technologies Inc.
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
                17.1.8.5.2. Product Strategy
                17.1.8.5.3. Channel Strategy
        17.1.9. BVM Medical Limited
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
                17.1.9.5.2. Product Strategy
                17.1.9.5.3. Channel Strategy
        17.1.10. Precision Extrusion Inc.
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
                17.1.10.5.2. Product Strategy
                17.1.10.5.3. Channel Strategy
        17.1.11. Cardiva
            17.1.11.1. Overview
            17.1.11.2. Product Portfolio
            17.1.11.3. Profitability by Market Segments
            17.1.11.4. Sales Footprint
            17.1.11.5. Strategy Overview
                17.1.11.5.1. Marketing Strategy
                17.1.11.5.2. Product Strategy
                17.1.11.5.3. Channel Strategy
        17.1.12. C. R. Bard, Inc.
            17.1.12.1. Overview
            17.1.12.2. Product Portfolio
            17.1.12.3. Profitability by Market Segments
            17.1.12.4. Sales Footprint
            17.1.12.5. Strategy Overview
                17.1.12.5.1. Marketing Strategy
                17.1.12.5.2. Product Strategy
                17.1.12.5.3. Channel Strategy
        17.1.13. Boston Scientific Corporation
            17.1.13.1. Overview
            17.1.13.2. Product Portfolio
            17.1.13.3. Profitability by Market Segments
            17.1.13.4. Sales Footprint
            17.1.13.5. Strategy Overview
                17.1.13.5.1. Marketing Strategy
                17.1.13.5.2. Product Strategy
                17.1.13.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Healthcare

Angiography Devices Market

July 2023

REP-GB-1186

333 pages

Healthcare

Angiogenesis Assays Market

July 2023

REP-GB-10030

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Angiographic Catheters Market

Schedule a Call